Thrifty White Drug Stores Chooses Gold Standard/Elsevier to Improve its Drug Dispensing System

By Elsevier And Gold Standardelsevier, PRNE
Tuesday, November 2, 2010

Pharmacists and Patients at Employee-Owned Retailer Will Use Alchemy for Accurate, Timely Medication Knowledge

TAMPA, Florida, November 3, 2010 - Gold Standard/Elsevier, developer of drug information and medication
management solutions, announced today that Thrifty White Drug Stores, an
employee-owned pharmacy with 88 stores in six states, has licensed Alchemy
(www.goldstandard.com/pages/alchemy.html?epm=1_1) as the new drug
database and decision support solution for all of its pharmacy and
telepharmacy dispensing systems.

"Thrifty White is committed to providing healthcare to populations where
access to pharmacy services is limited. We believe that the pharmacist is a
great resource, especially to patients in rural communities," said Gary
Boehler
, Executive Vice President of Pharmacy for Thrifty White. "We selected
Gold Standard's Alchemy due to its timely, reliable content, advanced
technology and excellent customer service. Alchemy offers the most complete
package to support us in giving our customers the quality care they need and
deserve."

Thrifty White emphasizes the use of technology to streamline the
prescription filling process so the pharmacist is available to counsel and
answer patients' questions. The company will use Alchemy's drug product
database, drug decision support and patient education to enhance their drug
dispensing system and provide drug information to pharmacists instantly.

Alchemy's Drug Product database delivers drug data compliant with NCPDP
telecommunication and electronic prescribing standards for brand and generic
prescription drugs, over-the-counter products, herbals, vitamins, nutritional
products, medical devices and diagnostic kits. Alchemy Drug Decision Support
evaluates the patient's complete drug regimen for potential problems and
presents concise, relevant notifications to help the healthcare provider make
informed drug therapy decisions. Alchemy also meets FDA requirements for
consumer medication information, with patient education sheets that serve as
counseling aids at the point of care and reassuring take-home references.

"Alchemy's agile technology will be able to keep pace with Thrifty
White's rapidly growing business, and its robust content will empower rural
communities with the most up-to-date drug information," said Marianne Messer,
president of Gold Standard. "By imparting medication knowledge to pharmacy
professionals and patients, Alchemy helps to produce fewer adverse drug
events, better health results, and an overall cost savings."

Alchemy is an integrated drug database and drug decision support engine
that improves clinical and financial outcomes. Better data modeling ensures
the most current and accurate drug content and decision support, while
superior customer service and advanced technology enable the simplest and
most cost-effective installation and maintenance. Alchemy delivers actionable
answers for users in all healthcare settings, leading the industry in
reducing alert fatigue for improved patient safety.

For more information on Alchemy, contact Gold
Standard/Elsevier at info@goldstandard.com or +1-800-375-0943.

About Gold Standard/Elsevier

Based in Tampa, FL, Gold Standard/Elsevier uses innovative
technologies to provide a complete suite of drug information and decision
support solutions. With a tenacious commitment to product quality, Gold
Standard/Elsevier solutions empower healthcare organizations, professionals
and consumers to meet the most pressing healthcare challenges, improve
patient safety and ensure optimal outcomes. To learn more about Gold
Standard/Elsevier, visit www.goldstandard.com.

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet (www.thelancet.com/) and Cell (
www.cell.com/), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com/), SciVerse Scopus
(www.scopus.com/home.url), Reaxys (
https://www.reaxys.com/reaxys/session.do), MD Consult (
www.mdconsult.com/php/225147780-2/homepage) and Nursing Consult
(www.nursingconsult.com/php/225147798-2/home.html), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com/) and MEDai's Pinpoint Review (www.medai.com/),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com/wps/find/homepage.cws_home) employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC (
www.reedelsevier.com/Pages/Home.aspx), a world-leading publisher and
information provider, which is jointly owned by Reed Elsevier PLC and Reed
Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London
Stock Exchange), RUK and ENL (New York Stock Exchange).

About Thrifty White

Headquartered in Maple Grove, MN, Thrifty White is a regional
chain of 88 pharmacies and 65 associated Independent Retailers operating in
the rural upper mid-west, with locations in Minnesota, North Dakota, South
Dakota
, Iowa, Montana and Wisconsin. Thrifty White is one of the nation's one
hundred largest Employee Stock Ownership companies, owned at least 51% by its
employees. In fact, the company is 100% owned by its employees. This unique
ownership structure allows Thrifty White to focus on the long term strength
and growth of the company.

    Media Contact:
    Tom Reller
    Vice President of Global Relations
    Elsevier
    +1-215-239-3508
    T.Reller@Elsevier.com

Media Contact: Tom Reller, Vice President of Global Relations, Elsevier, +1-215-239-3508, T.Reller at Elsevier.com

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :